India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

India is poised to capture a bigger share of the global pharmaceutical manufacturing market beyond generics, according to a ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

One of the world's biggest global health funders will ask the private sector for a steep increase in donations as concern of ...

Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue ...

The Pharmaceutical Technology Excellence Awards winners have been announced! Download our full 50+ page report to find out ...

Pharma stocks had a mixed response after Finance Minister Nirmala Sitharaman announced customs duty exemptions for 36 essential drugs and reduced rates for six others.

Out of the 41 analysts that have coverage on Sun Pharma, 30 of them have a 'Buy' rating on the stock. Seven of them have a ...

Expert Chahat Aggarwal anticipates a growing pharmaceutical industry backed by government initiatives in the Union Budget ...

The pharma major's consolidated net profit increased 15.04% to Rs 2,903.38 crore on 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24.

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...